Indiana University-Purdue University Indianapolis (IUPUI) / Root surface caries is an increasing problem in the United States as more of the population are retaining their teeth to an older age. The disease requires the recession of gingival tissue and resorption of alveolar bone prior to exposure of the root surface. Animal models for root surface caries provide a means to investigate the etiology and treatment of the disease. The Golden Syrian hamster has been used as a model, and alveolar bone loss and root exposure are induced by feeding the animals a high glucose diet. Significant bone loss, when compared to control groups, is usually detected within five weeks. At present, the use of non-steroidal anti-inflammatory drugs in the treatment of periodontal disease is an area of great interest. As there is a role of host response in the alveolar bone destruction seen in periodontitis, inhibition of this prostaglandin-mediated process may provide a means of treatment. Flurbiprofen (Ansaid™, Upjohn Co., Kalamazoo, Ml) has been widely studied and appears to inhibit this bone loss in a variety of animals, including man. The purposes of the study were to determine if the early alveolar bone loss occurring after three, four and five weeks' exposure to the high carbohydrate diet could be quantitated with fluorescent bone labels, and if this bone loss could be inhibited by daily administration of flurbiprofen. The animals received a series of four intraperitoneally-injected fluorochrome labels over a one-month period, then were fed ground lab chow, the high carbohydrate MIT-200GI diet or the MIT-200GI diet plus flurbiprofen. At the end of three, four and five weeks, animals were euthanized, and the mandibles were prepared for analysis. Statistical analysis of gross and histomorphometric measurements detected no significant differences between the experimental groups. It is suspected that the diets failed to produce periodontal disease in this experiment, possibly due to changes in the oral microflora caused by administration of tetracycline as the final bone label. There was much variation in the presence of bone labels, but they were able to provide the growth velocity of the alveolar complex. Flurbiprofen administration produced no measurable effects, but the animals did tolerate the dosage given. Future studies should consider variation of the labels and a different route of administration.

No description available.

Adult rats produce two main types of ultrasonic vocalizations (USVs), occurring at 22 and 50 kHz USVs. These calls are associated with aversive and rewarding stimuli, respectively. The neural mechanism of amphetamine-induced calling was examined in lesion and antagonist studies. We also tested whether amphetamine-induced 50 kHz USVs could predict individual differences in intravenous self-administration or conditioned place preference behavior. Further experiments examined whether 50 kHz USVs could be evoked by amphetamine-conditioned sensory stimuli and by rewarding electrical brain stimulation. Overall, our experimental findings: (1) identify certain experimental conditions that increase amphetamine-induced 50 kHz calling, (2) provide evidence that these calls may be dependent on mesolimbic dopaminergic transmission, (3) relate individual differences in 50 kHz vocalizing to other behavioural measures of drug reward, and (4) show that in some situations, 50 kHz calls reflect anticipation of expected rewards.

This research project investigates the long-term consequences of perinatal exposure to high-fat (HF) on the mesocorticolimbic dopamine (DA) system. Adult offspring of mothers fed a HF diet (30% fat, compared to 5% in control mothers (C)) during the last week of gestation and throughout lactation displayed decreased locomotion in response to an acute amphetamine challenge and decreased behavioral sensitization to repeated amphetamine compared to C animals. These behavioral effects were accompanied by small increases in tyrosine hydroxylase expression in the ventral tegmental area and significant increases in DA and DOPAC content in the NAc, suggesting an elevated DA tone in this target field. In the NAc, there were no significant changes in D1, D2 receptors or DA transporter (DAT) levels between diet groups. The behavioural and biochemical data were collected in adulthood, long after the termination of the diet suggesting that a HF perinatal diet is inducing permanent changes within the DA system and might contribute to the development of metabolic disturbances.

Diss. (sammanfattning) Uppsala : Sveriges lantbruksuniv. / Härtill 4 uppsatser.

Indiana University-Purdue University Indianapolis (IUPUI) / Introduction: Regenerative endodontic therapy in immature teeth with necrotic pulps triggers continued root development, thereby improving the prognosis of these teeth. Disinfection of the canal is accomplished with an intracanal medicament, such as triple antibiotic paste (TAP) composed of metronidazole, ciprofloxacin, and minocycline. A modified triple antibiotic paste (MTAP) that replaces minocycline with clindamycin has recently been suggested to avoid the tooth discoloration and potential demineralization from minocycline. The effect these pastes have on radicular dentin is unknown. Objectives: The aim of this study was to investigate the effects of two intracanal medicaments used during endodontic regeneration, TAP and MTAP, at concentrations of 1 g/mL and 1 mg/mL, on the microhardness and chemical structure of radicular dentin. Materials and Methods: Roots from extracted, unrestored, non-carious human premolar teeth were sectioned. An antibiotic paste (MTAP or TAP) or sterile water (control) was applied to treatment groups and stored for four weeks in 80-percent humidity at 37 °C. The effect of each paste on the microhardness of radicular dentin was measured using a Vickers Microhardness Tester (n = 17) to take three pretreatment and post-treatment measurements at both 500 µm and 1000 µm from the pulp-dentin interface. The chemical structure was assessed from dentin specimens treated with the same medicaments or sterile water for four weeks. After treatment, three measurements were taken on each specimen using Attenuated Total Reflection Fourier Transform Infrared Spectroscopy to measure the phosphate/amide I ratios of dentin (n = 7). Results: The 1 g/mL of TAP or MTAP and the 1 mg/mL methylcellulose-based TAP caused significant reduction in microhardness of roots compared with untreated control roots at 500 µm and 1000 µm from the pulp-dentin interface. Furthermore, the methylcellulose-based 1 mg/mL TAP and MTAP caused significantly less reduction in microhardness compared with 1 g/mL TAP and MTAP. The 1 g/mL of TAP and DAP caused significantly lower phosphate/amide I ratios compared with other groups. Conclusion: The use of methylcellulose based 1 mg/mL of TAP and MTAP may minimize the reduction in microhardness of roots compared with the currently used 1 g/mL concentration of these antibiotics.

No description available.

No description available.

No description available.

Infusões prolongadas de 5-fluorouracil são mais seguras e potencialmente mais efetivas no tratamento do câncer de cólon metastático do que infusões rápidas da mesma medicação. No entanto, infusões prolongadas requerem a disponibilidade de um acesso venoso central, bem como de bombas de infusão dispendiosas. O desenvolvimento de fluoropirimidinas orais permitiu que pacientes fossem expostos ao 5-fluorouracil por longo tempo, com maior conveniência. UFT e leucovorin administrados três vezes ao dia demonstraram previamente uma eficácia equivalente, com menor toxicidade, quando comparados a um regime convencional de infusão rápida de 5- fluorouracil e leucovorin. Este estudo com 98 pacientes foi desenhado e conduzido com objetivo de demonstrar equivalência no tempo de progressão com o uso de UFT e leucovorin administrados duas vezes ao dia, com o uso da mesma combinação administrada três vezes ao dia. Objetivos secundários incluíram análise de toxicidade, resposta objetiva e sobrevida global. O tempo mediano de progressão foi de 3,8 meses, comparado com 3,5 meses observados com o uso da medicação três vezes ao dia e a taxa de resposta foi de 11%, com uma sobrevida mediana de 12,8 meses, sendo comparável aos resultados de 12% e 12,4 meses obtidas com o uso da combinação três vezes ao dia. A incidência de diarréia com graus 3 e 4 foi de 30% no regime de administração duas vezes ao dia, e 21% no de três vezes ao dia. Esses resultados sugerem que o uso de UFT e leucovorin duas vezes ao dia tem eficácia e toxicidade similares àquelas obtidas com o uso da mesma medicação três vezes ao dia. / Prolonged infusions have been shown to be safer and potentially more effective than bolus regimens of 5- fluorouracil as treatment for advanced colorectal cancer. However, infusional 5- fluorouracil requires central venous access and costly infusion pumps. Development of oral fluoropyrimidines has allowed longer exposures to 5-fluorouracil with increased convenience. UFT and leucovorin given thrice daily showed improved safety and no significant difference in survival or response rate compared with bolus 5- fluorouracil and leucovorin. This study with 98 patients was conducted to evaluate whether UFT and leucovorin given twice daily provided comparable time to progression (TTP) to the same combination administered three times a day. Secondary objectives included evaluation of toxicity, overall tumor response rate, and survival. Median time to progression was 3.8 months, compared with 3.5 months observed with the thrice-daily regimen. The twice-daily regimen had a response rate of 11% and median survival of 12.8 months, comparable to the 12% and 12.4 months seen with the thrice-daily regimen. The incidence of grade 3-4 drug-related diarrhea was 30% on the twice-daily and 21% on the thrice-daily schedule. Results suggest that the twice-daily schedule has similar safety and efficacy to the thrice-daily schedule.